求助文献 四篇

5.Int J Hematol. 2007 Feb;85(2):121-7.The prophylactic effect of itraconazolecapsules and fluconazole capsules for systemic fungal infections in patientswith acute myeloid leukemia and myelodysplastic syndromes: a Japanesemulticenter randomized, controlled study.Ito Y, Ohyashiki K, Yoshida I, Takeuchi M,Aoyama Y, Mugitani A, Matsuura Y, Wakita H, Matsuda M, Sakamoto E, Kiguchi T,Urabe A, Tamura K, Kanamaru A, Masaoka T.

6.Bone Marrow Transplant. 2006 Jul;38(2):127-34.Epub 2006 Jun 5.A prospective randomized trial of itraconazolevs fluconazole for the prevention of fungal infections in patients with acuteleukemia and hematopoietic stem cell transplant recipients.Oren I, Rowe JM, Sprecher H, Tamir A, BenyaminiN, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.

7.J Infect Chemother. 2003 Mar;9(1):40-5.Itraconazole is not effective for theprophylaxis of fungal infections in patients with neutropenia.Kaptan K, Ural AU, Cetin T, Avcu F, Beyan C,Yalçin A.

8.Br J Haematol. 1999 Jun;105(4):901-11.A randomized controlled trial of itraconazoleversus fluconazole for the prevention of fungal infections in patients withhaematological malignancies. U.K. Multicentre Antifungal Prophylaxis StudyGroup.Morgenstern GR, Prentice AG, Prentice HG, RopnerJE, Schey SA, Warnock DW.

第一篇

第二篇

第三篇

第四篇